Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer-Reference-Cited by-同舟云学术

Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer

Published:2023-01-04 Issue:6 Volume:128 Page:1155-1165
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kosumi Keisuke,Baba Yoshifumi^ORCID,Yamamura Kensuke,Nomoto Daichi,Okadome Kazuo,Yagi Taisuke,Toihata Tasuku,Kiyozumi Yuki,Harada Kazuto,Eto Kojiro,Sawayama Hiroshi,Ishimoto Takatsugu^ORCID,Iwatsuki Masaaki,Iwagami Shiro,Miyamoto Yuji,Yoshida Naoya,Watanabe Masayuki,Baba Hideo^ORCID

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-02112-x.pdf

Reference65 articles.

1. Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17:286–301.

2. Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA Jr, et al. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. https://doi.org/10.1136/gutjnl-2017-315537 2018.

3. Mlecnik B, Bindea G, Angell HK, Maby P, Angelova M, Tougeron D, et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity. 2016;44:698–711.